Third call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates
Diversifying the vaccine development pipeline has been recognized as a priority in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium has successfully secured funding for a four-year project that aims to fill the early stages of the development pipeline while ensuring a diverse portfolio of vaccine candidates (TBVAC-HORIZON – TBVI). One of the key […]
TBVI Awardees 2025
With the TBVI Award, TBVI encourages promising scientists and rewards their remarkable contributions to tuberculosis (TB) vaccine research and development, by offering them the opportunity to present their work at the TBVI symposium that takes place 28-29 January 2025 in Les Diablerets. This annual meeting is dedicated to the exchange of knowledge and the fostering […]
Announcement TBVI Award 2025
Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents the TBVI Awards. Promising scientists are given the opportunity to give a 15-minute presentation (incl. discussion) about their work during the annual TBVI symposium where researchers, policy […]
TBVI and EVI team up with VAC4EU
TBVI and EVI announce a new partnership with Vaccine Monitoring Collaboration for Europe (VAC4EU). VAC4EU is a pan-European research network for post-authorisation vaccine safety and benefit monitoring, specialised in the collaborative generation of real-world evidence on coverage, safety, and efficacy of vaccines in Europe. TBVI and EVI are both European non-profit Product Development Partnerships (PDPs) […]
Biofabri and TBVI sign a contract with the European Health and Digital Executive Agency to accelerate the final development of the new TB vaccine MTBVAC
Biofabri and TBVI have signed a contract with the European Health and Digital Executive Agency (HaDEA) under the EU4Health Programme to accelerate the final development of the MTBVAC vaccine. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of […]
Vacancy at TBVI for a Scientific Project Manager
TBVI has an exciting career opportunity for a motivated individual to join the organisation as Scientific Project Manager (full-time or part-time). You will join a small, enthusiastic team, dedicated to TBVI’s goals to relieve the burden of TB and eliminate tuberculosis around the world. Applications with the requested information should be submitted in English and […]
7th Global Forum on TB Vaccines – Participant support
As we believe that no one should be left out of the conversation, we offer travel and registration support (participant support) for participants planning to attend the 7th Global Forum on TB Vaccines. Support is available for students, post-docs, early career researchers, advocates, members of affected communities, and participants from LMICs. For more information, please […]
Second call for applications to assess efficacy of Mycobacterium tuberculosis vaccine candidates in a mouse model
Diversification of the vaccine development pipeline has been identified as a priority area in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium aims, amongst other things, to fill the early phases of the development pipeline while ensuring a diverse portfolio (TBVAC-HORIZON – TBVI). One of the objectives of the project is to perform head-to-head […]
University of Oxford (UOXF) starts aligned clinical study – first participant enrolled
TBVAC-HORIZON has met an important milestone: On 3 April 2024, the first participant in the UOXF “TB46” study was enrolled. Tuberculosis (TB) remains one of the most devastating infectious diseases worldwide, killing over 4,000 people every day. Prevention of TB infection by novel vaccines would provide the most cost-effective approach to achieve the goals of […]
7th Global Forum on TB vaccines – Call for abstracts
The Global Forum on TB Vaccines will take place from 8-10 October 2024 and will be hosted in Rio de Janeiro, Brazil. The Call for Abstracts for the 7th Global Forum on TB Vaccines is now available. Researchers, product developers, advocates, community representatives, and others engaged in new TB vaccines are encouraged to submit. Submissions […]